chrisvoncsefalvay/vaers-outcomes huggingface dataset:
administered exposed vaccines, 52 Fahrenheit; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received Herpes zoster (Shingrix) (batch number 7P2PS, expiry date 2nd June 2023), (batch number 75B29, expiry date 24th August 2023) and (batch number 24LA3, expiry date 7th July 2023) for prophylaxis.   On 31st March 2022, the patient received Shingrix. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 20-Jul-2022 Reporter's comment: The medical assistant called in to check stability of vaccines exposed on 29th March 2022, as Shingrix and Boostrix, 52 Fahrenheit for 3 months. The reporter reported that 20 patients were administered the exposed vaccines, 15 patients were administered the Shingrix and 5 patients were administered Boostrix. The reporter stated that Boostrix details were unknown. The reporter was unable to provide any additional details. The reporter did not consent to follow-up. Additional supportive information: The patient received a dose of Shingrix which was exposed at 52 Fahrenheit for 3 months, which led to incorrect storage of drug. This is 1 out of 20 linked cases, reported by same reporter. As it was not clear from which Lot which patient received the vaccine, therefore conservatively all the Lot details were coded in sub tab of product details.; Sender's Comments:  US-GSK-US2022AMR109267:same report, other patient US-GSK-US2022AMR109268:same report, other patient US-GSK-US2022AMR109269:same report, other patient US-GSK-US2022AMR109270:same report, other patient US-GSK-US2022AMR109271:same report, other patient US-GSK-US2022AMR109272:same report, other patient US-GSK-US2022AMR109273:same report, other patient US-GSK-US2022AMR109274:same report, other patient US-GSK-US2022AMR109275:same report, other patient US-GSK-US2022AMR109276:same report, other patient US-GSK-US2022AMR109265:same report, other patient US-GSK-US2022AMR109264:same report, other patient US-GSK-US2022AMR109263:same report, other patient US-GSK-US2022108790:same report, other patient US-GSK-US2022AMR109266:same report, other patient US-GSK-US2022AMR109278:same report, other patient US-GSK-US2022AMR109279:same report, other patient US-GSK-US2022AMR109280:same report, other patient US-GSK-US2022AMR109281:same report, other patient
wrongful death; shingles; Information has been received from a lawyer concerning a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, historical conditions and concomitant therapy were not reproted. On or aobut 13-MAR-2015, the 63-years-old patient was vaccinated with a dose of zoster vaccine live( ZOSTAVAX) (dose, route of administration, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions in a pharmacy by a pharmacist. Subsequently, the patient was treated by a healthcare provider at a family practice for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: shingles. The outcome of shingles was unknown. Specific allegations also included wrongful death on an unspecified date. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
Did fine p/vax given 17MAR92; broke out w/rash & had thrush 24MAR92 w/OM states had contact dermatitis w/OM & thrush;
Limited strength in right arm; Pain; Had a right tender injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Limited strength in right arm), PAIN (Pain) and VACCINATION SITE PAIN (Had a right tender injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 026B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN and GLIPIZIDE for Diabetes, SIMVASTATIN for High cholesterol.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (Limited strength in right arm), PAIN (Pain) and VACCINATION SITE PAIN (Had a right tender injection site). At the time of the report, MUSCULAR WEAKNESS (Limited strength in right arm) and PAIN (Pain) outcome was unknown and VACCINATION SITE PAIN (Had a right tender injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment included Advil, Aleve, oils for injection site.   This case was linked to MOD-2021-310838 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2021: Significant FU received on 14 Sep 2021,contain Reporter Address,Patient Height,Weight and Race Information and events were added. On 14-Sep-2021: Follow-up information included no new information
11/18/08 Headache;11/19/08 Rhinitis, Malaise, Dizziness, Edema in eyes.  Note: This symtoms continues until 12/10/08.   12/10/08 2:00 a.m. convulsions and patient was hospitalized with R/O TIA vs CNS infection. Note: Patient still at Hospital.
Patient presented to hospital with acute hypoxemic resp failure. Pt had history of COVID19 infection in Nov 2020. Pt has chronic medical conditional including but not limited to marginal zone lymphoma on chemo, h/o aspergillus, MAC on atovoqone and voriconazole. Pt received moderna vaccine in May (1st shot), and June (2nd shot). Pt admitted on 7/16 found to have positive covid infection second time. Pt resp status steadily worsen from NC to reservoir, and then HFNC. Despite on remdesivir, prednisone, antibiotics, and antifungal. Pt had code blue due to resp arrest, intubated, then coded again in ICU for over 1 hour. Family elevated make patient DNR, and she died soon after on 7/20.
I developed a cough and nasal congestion early 10/14, tested negative for COVID. Re-tested 10/15, tested positive. I phoned my physician and was prescribed Paxlovid based on my phone call, began Paxlovid on 10/15. My symptoms rapidly improved, and I never had a fever. I tested negative on 10/19 and again on 10/21. After I reported my positive test to V-Safe, I was called by the CDC. They said it could be helpful to complete a VAERS form to document the post- vaccine case.
PATIENT DEVELOPED NUMBNES IN LEFT ARM ABOUT 15 MINUTES AFTER ADMINISTRATION OF MODERNA COVID-19 VACCINE IN LEFT DELTIOD MUSCLE. PATIENT REPORTS TAKING TYLENOL AFTER RECIVING VACCINE. PATIENT REPORTS NUMBNESS IN LEFT ARM HAS IMPROVED SIGNIFICANTLY ABOUT 4 HOURS AFTER RECIVING VACCINE.
her eyes were glazed over/eyes were cloudy, blurry, and then blacked out /passing out; headache; nauseous; feeling unwell; wobbly/ felt a little weird; her eyes were glazed over/eyes were cloudy, blurry, and then blacked out; she said she started feeling kind of dizzy; This is a spontaneous report from a contactable consumer. A 12-years-old female patient (daughter) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number and expiration date was not reported), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer COVID 19 vaccine around 11:30 yesterday. She states that she felt fine for the remainder of the day yesterday but that this morning she had a headache and was nauseous. She states that they had plans to attend a lunch with family but had delayed it due to her daughter feeling unwell so they waited for few hours just waiting to see if she would improve then after few hour she said okay the nausea was gone and after a few hours the daughter was feeling better and they proceeded to go to lunch. When the daughter got out of the car to go to lunch the mother states that she was wobbly and her eyes were glazed over. Then all of a sudden she said she started feeling kind of dizzy like she said her eyes kind of looked cloudy, she felt a little weird and she ended up passing out and had to catch her as she was falling. She reports that she then lost her footing and fell to the ground but that she was able to catch her somewhat. She states that she whole episode lasted about 15 seconds and then she came to. The daughter reports that her eyes were cloudy, blurry, and then blacked out. She states that she is not sitting and eating a banana and feeling okay. Should she get the second dose since she had side effects from the first dose. Response: As noted in the Fact Sheet for Recipients, you should not get the Pfizer-BioNTech COVID-19 Vaccine if you had a severe allergic reaction after a previous dose of the vaccine or if you had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. We refer you to speak to your healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. Your healthcare provider knows your health situation and has access to information that can better help inform this decision. Outcome of the event nausea was recovered and outcome of the other events were unknown.  Information on the Lot/Batch number has been requested.  Follow-up (16May2021): This is a follow up-spontaneous report from a contactable consumer. This consumer Reported for 12-year-old female patient (daughter) that: outcome of the event was updated.  Information on the Lot/Batch number has been requested.
devel diff breathing approx 345PM;pt given DPH, solumedro, zantac, epi;pt released w/DPH, pred to be taken for 5 dasy;
p/vax pt devel rxn the size of  1/2 dime size;DPH given site was cont checked until rxn site went down;
Pt states after vaccine she developed dizziness throughout the day, 3 days straight and again on Sunday 3/26/15. She's concern the length of dizziness may interfere with her daily functions.
33 year old female patient fainted on-site after receiving a vaccine around 10:16 am, roughly 3 minutes after receiving the vaccine. Her partner was able to catch her from falling to the ground and on-site EMS was brought over to do further assessment. EMS provided fluids on-site and then transported via EMS to local hospital.  Patient reported fainting after vaccines in the past.
Four days fever, fatigue, nausea, headache, chills, muscle aches, dizziness, low bp  Recently, intense itching on toes and feet and palms post vaccine on day 11-14
After patient received second dose of SHINGRIX vaccine, he noticed his arm was numb. It has still remained numb and radiates to his shoulder.
right hip/ leg  aching pain with difficulty ambulating for at least 7 days after symptom onset .  took ibuprofen for pain
Got my booster shot and got sick all over again/Could not get out of bed; Dizzy; Didn't know who was in the room; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A 75-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization, reaction(s): "Dizzy", "extremely sick", "Could not get out of bed", "Didnt know who was in the room"; Bnt162b2 (Dose 2), for COVID-19 immunization, reaction(s): "Dizzy", "extremely sick", "Could not get out of bed", "Didnt know who was in the room". The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Got my booster shot and got sick all over again/Could not get out of bed"; DIZZINESS (non-serious), outcome "unknown", described as "Dizzy"; MEMORY IMPAIRMENT (non-serious), outcome "unknown", described as "Didn't know who was in the room". The events "got my booster shot and got sick all over again/could not get out of bed", "dizzy" and "didn't know who was in the room" required emergency room visit.  Additional information: The patient was taken to the ER though the patient was in good health.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201283470 same patient/drug/events, different dose;
wrong vaccine was administered to the patient. Patient was only 11.5 years old but received Pfizer bivalent 12+ instead of kids bivalent 5-11
Developed rash on 05/04/2019, seen in office, Dx with  Pityriasis Rosea with Hearld patch. Given 1% Hydrocortisone cream.  Seen 05/06/19 for continued watery stools which started on 05/04/19. Had 1-2 normal stools. No fevers, is taking in fluids but less than usual amounts. Overall affect happy but is a bit fussy at times.  Monitoring, is to return to office if not resolved in 48 hours or worsens.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA lot # K009506 exp. 22-SEP-2016, (dose and route were not provided). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Soreness in arm the next day. Went away after a couple of weeks. About 3-4 days after receiving the shot, I developed pretty extreme jaw tension that has lasted 1 month later. It's a daily thing. Some days it seems to be a little better, and then the next day, it feels like body builder hands on pushing in on either side of my jaw joints. PCP confirms its not tmj. Nothing else had changed in my life around the time it started. I wear a night guard so it wasn't from grinding teeth at night. I've never experienced anything like this before.
localized raised, bumpy, itchy rash. Treated w/previously received prescription Lidex
2-26-2021 woke up with swollen face and eye lids. member states unable to open eyes.  Took OTC Benadryl and swelling resolved over 24 hours
Later in the day after the vaccine was administered, the patient began having an aching in all joints that continued into the next day. On the third day, she woke up to swelling and redness in her right cheek that began to move upward into her eye and eyelid. The skin was warm to the touch and the right cheekbone and inner eye orbital was very painful to the touch. The next day the right eye was swollen completely shut and there was eye pain. It has begun to move into the left eye at this point.
Malaise; right ancillary lymph node swelling and pain/Armpit swelling and pain; right ancillary lymph node swelling and pain/Armpit swelling and pain; headache (stingy like a migraine); fatigue; Armpit swelling and pain is unique to third shot.; Armpit swelling and pain is unique to third shot.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 16Nov2021 09:30 (Lot number: FH8030) at the age of 49 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: Jan2021 (unspecified if ongoing), notes: Had covid in Jan 2021. Concomitant medication(s) included: INFLUENZA VACCINE, administration date 11Oct2021. Vaccination history included: Bnt162b2 (Dose 2, Batch/Lot No: EW0172, Location of injection: Right : Arm, Vaccine Administration Time: 12:00 PM), administration date: 28Apr2021, when the patient was 48 years old, for COVID-19 Immunization; Bnt162b2 (Dose 1, Batch/Lot No: EP8834, Location of injection: Right Arm, Vaccine Administration Time: 10:30 AM), administration date: 06Apr2021, when the patient was 48 years old, for COVID-19 Immunization, reaction(s): "Had same kind of headache with first". The following information was reported: MALAISE (non-serious) with onset 16Nov2021 18:00, outcome "not recovered", described as "Malaise"; LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 16Nov2021 18:00, outcome "not recovered" and all described as "right ancillary lymph node swelling and pain/Armpit swelling and pain"; HEADACHE (non-serious) with onset 16Nov2021 18:00, outcome "recovered" (18Nov2021), described as "headache (stingy like a migraine)"; FATIGUE (non-serious) with onset 16Nov2021 18:00, outcome "not recovered", described as "fatigue"; SWELLING (non-serious), AXILLARY PAIN (non-serious) all with onset 16Nov2021 18:00, outcome "not recovered" and all described as "Armpit swelling and pain is unique to third shot.". Therapeutic measures were not taken as a result of malaise, lymphadenopathy, lymph node pain, headache, fatigue, swelling, axillary pain.  Additional information: patient was not tested for covid post vaccination. had no known allergies. Vaccination facility: Pharmacy or Drug Store.  No follow-up attempts are possible. No further information is expected.
First adverse reaction was a headache behind right ear.  This was a throbbing pain. Had low energy and a feeling of unwell.  On 5/10/2021 had bad headache behind right ear.  On 5/12/2021 I began swelling on the right side of my face with numbness on my right side lip area.  On 5/13/2021 my face was fully distorted.  On 5/13/2021 my neurologist diagnosed me with Bell's Palsy (G51.0).  Neurologist ordered me on Prednisone 20mg three times per day for one week and initiate Physical Therapy.  Ordered a blood test for Lyme disease.
PATIENT COMPLAINED OF A RASH APPEARING ON BOTH PALMS MOVING UP TO BOTH ELBOWS. PATIENT TRIED BENADRYL AND CALLED HER DOCTOR. DOCTOR SAID TO CONTINUE WITH BENADRYL AND TRY HYDROCORTISONE CREAM, IF NO RELIEF COME TO OFFICE IN THE MORNING.
Dizziness, lightheadedness, feeling faint,  constant tiredness, heart palpitations
Dizzy; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and penicillin allergy. Concomitant medications included levothyroxine sodium (LEVOTHROID) and colecalciferol, calcium (CALTRATE BONE HEALTH) and multivitamins; all taken for unspecified indication from an unknown date and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 13:00, after 6 days of first dose, the patient became dizzy, had nausea, really bad dizziness which lasted for 3 days, stayed in bed mostly, the fourth day the patient felt better, almost normal, the next morning the patient woke up dizzy again and had to stay mostly in bed for another 2 days. The patient was healthy, exercise every day. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizzy and nausea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 08-NOV-2016, the patient was vaccinated with improperly stored dose of M-M-R II (lot# L043702 with expiration date 03-NOV-2017; site, dose and route of administration were not reported). The reason of the call was temperature alarm received via Digital Data Logger. It was reported that the vaccine was exposed to temperature of -14.4 Celsius degrees for 54 minutes before administration to the patient. No previous temperature excursion was reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained. Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA010816: US-009507513-1705USA010817: US-009507513-1705USA010818: US-009507513-1705USA010819: US-009507513-1705USA010820: US-009507513-1705USA010821: US-009507513-1705USA010822: US-009507513-1705USA010823: US-009507513-1705USA010824: US-009507513-1705USA010825: US-009507513-1705USA010826: US-009507513-1705USA010827: US-009507513-1705USA010828: US-009507513-1705USA010829: US-009507513-1705USA010830: US-009507513-1705USA010831: US-009507513-1705USA010832: US-009507513-1705USA010833: US-009507513-1705USA010834: US-009507513-1705USA010835: US-009507513-1705USA010836: US-009507513-1705USA010837: US-009507513-1705USA010838: US-009507513-1705USA010839: US-009507513-1705USA010840: US-009507513-1705USA010841: US-009507513-1705USA010842: US-009507513-1705USA010843: US-009507513-1705USA010844: US-009507513-1705USA010845: US-009507513-1705USA010846: US-009507513-1705USA010847: US-009507513-1705USA010848: US-009507513-1705USA010849: US-009507513-1705USA010850: US-009507513-1705USA010851: US-009507513-1705USA010852: US-009507513-1705USA010853: US-009507513-1705USA010854: US-009507513-1705USA010855: US-009507513-1705USA010856: US-009507513-1705USA010857: US-009507513-1705USA010858: US-009507513-1705USA010859: US-009507513-1705USA010860: US-009507513-1705USA010861: US-009507513-1705USA010862: US-009507513-1705USA010863: US-009507513-1705USA010864: US-009507513-1705USA010865: US-009507513-1705USA010866: US-009507513-1705USA010867: US-009507513-1705USA010868: US-009507513-1705USA010869: US-009507513-1705USA010870: US-009507513-1705USA010871: US-009507513-1705USA010872: US-009507513-1705USA010873: US-009507513-1705USA010874: US-009507513-1705USA010875: US-009507513-1705USA010876: US-009507513-1705USA010877: US-009507513-1705USA010878: US-009507513-1705USA010879: US-009507513-1705USA010880: US-009507513-1705USA010881: US-009507513-1705USA010882.
This spontaneous report as received from a 69  year old male patient refers to himself. The patient was being treated with chemotherapy also suffers from depression, high blood pressure, multi-myeloma and thyroid disorder. There were no drug reactions/allergies. Between 2008 and 2009 the patient was vaccinated with a dose of PNEUMOVAX23 (dose, route and lot # not reported) in the arm. Concomitant therapies included REVLLIMID, dexamethasone (manufacturer unknown), ADVAIR and LEVOXYL. it was reported that on 13-AUG-2014 the patient was diagnosed with pneumonia. Pneumonia consisted of "yellowish phlegm." The patient also noted that he "got sicker" and "had more difficulty breathing". The patient treated with azithromycin, 5 day round, 2 tablets on 18-AUG-2014 followed by a pill each day after that. X-ray and blood test were performed (result unspecified). The outcome of pneumonia was reported as recovering/resolving at the time of reporting. The patient sought medical attention by talking with physician. Additional information has been requested.
pt adm w/paresthesia & weakness;pt devel tingling both hands & forearms on 20MAY97;23MAY97 pt reported tingling feeling in toes, tongue & lips;pt devel weakness & felt off balance when walking;neuro noted early GBS poss d/t pneumovax;